1 Stock Under $50 to Target This Week and 2 That Underwhelm
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.
Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. Keeping that in mind, here is one stock under $50 with huge potential and two best left ignored.
Two Stocks Under $50 to Sell:
Quanex (NX)
Share Price: $21.13
Starting in the seamless tube industry, Quanex (NYSE:NX) manufactures building products like window, door, kitchen, and bath cabinet components.
Why Is NX Risky?
- Projected sales are flat for the next 12 months, implying demand will slow from its two-year trend
- Incremental sales over the last two years were much less profitable as its earnings per share fell by 14.1% annually while its revenue grew
- Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results
Quanex’s stock price of $21.13 implies a valuation ratio of 10.8x forward P/E. If you’re considering NX for your portfolio, see our FREE research report to learn more.
Home Bancshares (HOMB)
Share Price: $30.21
Founded in Conway, Arkansas in 1998 and growing through strategic acquisitions across the Southeast, Home Bancshares (NYSE:HOMB) operates as the bank holding company for Centennial Bank, providing commercial and retail banking services to businesses and individuals across multiple states.
Why Do We Think Twice About HOMB?
- Net interest income trends were unexciting over the last five years as its 9.6% annual growth was below the typical banking firm
- Estimated net interest income growth of 5.9% for the next 12 months implies demand will slow from its five-year trend
- Incremental sales over the last five years were less profitable as its 6.1% annual earnings per share growth lagged its revenue gains
At $30.21 per share, Home Bancshares trades at 1.3x forward P/B. Check out our free in-depth research report to learn more about why HOMB doesn’t pass our bar.
One Stock Under $50 to Watch:
Pfizer (PFE)
Share Price: $27.54
With roots dating back to 1849 when two German immigrants opened a fine chemicals business in Brooklyn, Pfizer (NYSE:PFE) is a global biopharmaceutical company that discovers, develops, manufactures, and sells medicines and vaccines for a wide range of diseases and conditions.
Why Are We Positive on PFE?
- Enormous revenue base of $63.7 billion gives it economies of scale and advantages over new entrants due to the industry’s regulatory complexity
- Adjusted operating margin expanded by 18.5 percentage points over the last two years as it scaled and became more efficient
- Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures
Pfizer is trading at $27.54 per share, or 10x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.